Tag: Cancer

  • Health

    New drug extends life of melanoma patients

    A therapy that multiplies the effect of a natural disease-fighting antibody has extended the lives of patients with metastatic melanoma in a large, international clinical trial.

    3–5 minutes
  • Campus & Community

    Bench pressing for a cure

    On May 3, more than 250 Harvard athletes from 18 varsity teams took the Palmer-Dixon Gymnasium by storm for the second annual Bench Press for Breast Cancer Challenge, pumping iron and raising greenbacks for the Susan G. Komen for the Cure.

    3–4 minutes
  • Campus & Community

    Evening with Champions

    With her spotlight purring like an old projector, Linda Yao ’10 used a steady hand to follow the cast of famed figure skaters as they shaved graceful ribbons into the ice during “An Evening with Champions.”

    1–2 minutes
  • Arts & Culture

    Peering into gearworks of FDA

    Daniel Carpenter’s new book, “Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA,” probes the workings of a crucial federal safety agency that often is either lionized or demonized.

    2–3 minutes
  • Nation & World

    Sumner M. Redstone donates $1M

    Harvard University today (April 23) announced that Sumner M. Redstone has contributed $1 million to be used by Harvard College and Harvard Law School. This contribution by Redstone, a graduate of both Schools, will establish scholarships for 20 Redstone Scholars to attend Harvard College for the 2010–11 academic year.

    4–5 minutes
  • Campus & Community

    Diabetes drug tied to reduced breast cancer risk

    Women who have used the diabetes drug metformin for more than five years may have a lower risk of breast cancer than diabetic women on other treatments, a new study finds…

    1–2 minutes
  • Campus & Community

    Radiation use may raise adult cancer risk

    NEW YORK — Women’s risk of developing breast cancer may increase as much as 20-fold if they were treated with chest radiation for malignancies as children or young adults, according…

    1–2 minutes
  • Health

    Childhood cancer survivors may face shortened lifespan, study reveals

    Although more children today are surviving cancer than ever before, young patients successfully treated in the 1970s and 80s may live a decade less, on average, than the general population,…

    4–6 minutes
  • Health

    Treatment resistance in some cancer cells may be reversible

    The ability of cancer cells to resist treatment with either targeted drug therapies or traditional chemotherapy may, in some cases, result from a transient state of reversible drug “tolerance.”  In…

    2–3 minutes
  • Health

    “Good” cells can go “bad” in a “bad neighborhood”

    Normal.dotm 0 0 1 375 2142 Harvard University 17 4 2630 12.0 0 false 18 pt 18 pt 0 0 false false false The general theory of cancer development holds…

    2–3 minutes
  • Campus & Community

    Second opinions, anywhere

    Rwanda has 10 million people, but no cancer specialists. A recent collaboration between a Waltham medical information company and a Harvard University research institute aims to reduce such professional isolation – and to learn from the medical knowledge and resourcefulness of doctors in the developing world.

    1–2 minutes
  • Campus & Community

    Stem Cell Experiment Reverses Aging In Rare Disease

    The team at Children’s Hospital Boston and the Harvard Stem Cell Institute were working with a new type of cell called induced pluripotent stem cells or iPS cells, which closely resemble embryonic stem cells but are made from ordinary skin cells…

    1–2 minutes
  • Health

    The hunt for healthy answers

    JoAnn Manson leads a nationwide study to assess whether vitamin D and omega-3 fatty acids can boost immunity and protect against ailments from heart disease to cancer.

    4–6 minutes
  • Campus & Community

    Daffodil Days in full bloom

    At Harvard, the month of February brings the promise of spring with the kick-off of Daffodil Days, a University-wide effort to raise funds to support the fight against cancer.

    1–2 minutes
  • Health

    Genes linked to breast cancer drug resistance

    Harvard researchers at the Dana-Farber Cancer Institute have discovered a “gene activity signature” that predicts a high risk of cancer recurrence in some breast tumors that have been treated with…

    4–6 minutes
  • Health

    Want to live well?

    Harvard faculty members from a range of fields give tips on how to live healthy.

    9–14 minutes
  • Health

    Cancer vaccine success

    A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week (Nov. 25) in the journal Science Translational Medicine.

    2–4 minutes
  • Health

    First cancer vaccine to eliminate tumors in mice

    A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, a team of Harvard bioengineers and biologists report…

    2–4 minutes
  • Health

    Researchers ‘NOTCH’ a victory in war on cancer

    Normal 0 0 1 819 4673 38 9 5738 11.1282 0 0 0 Scientists have devised an innovative way to disarm a key protein considered to be “undruggable,” meaning that…

    4–6 minutes
  • Health

    Darkness with the light

    Adult survivors of childhood cancer have an increased risk of suicidal thoughts, even decades after their cancer treatments have ended, according to a study led by Harvard researchers at Dana-Farber…

    3–5 minutes
  • Health

    Researchers exploit genetic ‘co-dependence’ to kill treatment-resistant tumor cells

    Cancer cells fueled by the mutant KRAS oncogene, which makes them notoriously difficult to treat, can be killed by blocking a more vulnerable genetic partner of KRAS, report scientists at…

    3–5 minutes
  • Campus & Community

    A Cancer Visible To The Naked Eye, But Doctors Aren’t Looking

    “We were very, very surprised,” Geller recalls. “About three-quarters of them were never trained in the skin cancer exam, and more than half never once practiced the examination during their primary care residency.” Geller, who’s a senior research scientist at the Harvard School of Public Health, says those high levels of inexperience are really worrisome.…

    1–2 minutes
  • Campus & Community

    Study Finds Pro and Cons to Prostate Surgeries

    People intuitively think that a minimally invasive approach has fewer complications, even in the absence of data,” said Dr. Jim C. Hu, the study’s lead author, who is director of urologic robotic and minimally invasive surgery at Brigham and Women’s Hospital in Boston.

    1–2 minutes
  • Campus & Community

    U.S. study shows mammograms save lives

    “The most effective method for women to avoid death from breast cancer is to have regular mammographic screening,” Dr. Blake Cady of Cambridge Hospital Breast Center and Harvard Medical School in Massachusetts told reporters in a telephone briefing…

    1–2 minutes
  • Campus & Community

    Telomerase work wins Szostak Nobel Prize in medicine

    Jack W. Szostak, a genetics professor at Harvard Medical School and Harvard-affiliated Massachusetts General Hospital (MGH), has won the 2009 Nobel Prize in physiology or medicine for work on cellular structures called telomeres, which protect chromosomes from degradation.

    5–7 minutes
  • Campus & Community

    Aspirin Can Prevent Colon Cancer in High-Risk Group, Study Says

    The Harvard study suggested aspirin could prevent tumors from growing by inhibiting Cox-2, an enzyme that may play a role in the initial growth of a tumor.

    1–2 minutes
  • Campus & Community

    Diabetes Medication May Get New Life as Cancer Treatment

    A national tax of 1 cent per ounce of soda and other sugary drinks could stem the United States’ obesity epidemic, while generating $14.9 billion the first year alone, health experts say.

    1–2 minutes
  • Campus & Community

    Does Infection Boost Prostate Cancer Risk?

    In the new study, Jennifer Stark of the Harvard School of Public Health in Boston and colleagues analyzed blood samples from 673 men with prostate cancer who participated in the Physicians’ Health Study, a large, ongoing study examining a variety of health issues.

    1–2 minutes
  • Health

    New metabolic safeguards against tumor cells revealed

    Cells don’t like to be alone. In the early stages of tumor formation, a cell might be pushed out of its normal home environment due to excessive growth. But a…

    3–5 minutes
  • Health

    Study supports DNA repair-blocker research in cancer therapy

    Scientists at Dana-Farber Cancer Institute have uncovered the mechanism behind a promising new approach to cancer treatment: damaging cancer cells’ DNA with potent drugs while simultaneously preventing the cells from…

    3–5 minutes